Literature DB >> 10587245

Intra-articular hyaluronic acid: duration of effect and results of repeated treatment cycles.

R Kotz1, G Kolarz.   

Abstract

An open-label, multicenter study was designed to evaluate the effects of intra-articular (IA) hyaluronic acid in patients given a diagnosis of osteoarthritis of the knee. Patients (n = 108) received five weekly IA injections of hyaluronic acid 20 mg (Hyalgan) under sterile conditions, and were observed for up to 12 months after the last injection. Some patients received a second series of injections after 4 to 8 months. For the 59 patients who were observed for 12 months after the first treatment cycle, evaluation of pain according to a visual analog scale showed significant improvements lasting 12 months, with pain during load, pain at rest, and duration of walking ability compared with a baseline evaluation. Patients who required a second treatment cycle showed a further amelioration. Significant improvements were also seen in knee function and in global evaluations by both patient and investigators. Relief of symptoms of osteoarthritis of the knee was seen as early as 4 weeks after treatment in 68% of patients receiving IA hyaluronic acid. In 55% of these patients, relief was maintained until the end of the 12-month follow-up.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10587245

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  16 in total

Review 1.  [A synopsis of medication for degenerative osteoarthritis].

Authors:  J Grifka; U Müller-Ladner
Journal:  Orthopade       Date:  2004-07       Impact factor: 1.087

Review 2.  Viscosupplementation for osteoarthritis: a primer for primary care physicians.

Authors:  M Carrington Reid
Journal:  Adv Ther       Date:  2013-11-08       Impact factor: 3.845

Review 3.  Hyaluronic acid supplementation.

Authors:  R W Moskowitz
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

4.  The safety and efficacy of intraarticular hyaluronan with/without corticosteroid in knee osteoarthritis: 1-year, single-blind, randomized study.

Authors:  Cihat Ozturk; Funda Atamaz; Simin Hepguler; Mehmet Argin; Remide Arkun
Journal:  Rheumatol Int       Date:  2005-02-10       Impact factor: 2.631

5.  Retrospective study of outcomes in hyalgan®-treated patients with osteoarthritis of the knee.

Authors:  John P Barrett; Paola Siviero
Journal:  Clin Drug Investig       Date:  2002       Impact factor: 2.859

Review 6.  Hyaluronic acid injections for knee osteoarthritis. Systematic review of the literature.

Authors:  Anita Aggarwal; Ian P Sempowski
Journal:  Can Fam Physician       Date:  2004-02       Impact factor: 3.275

Review 7.  Viscosupplementation with hyaluronans for osteoarthritis of the knee: clinical efficacy and economic implications.

Authors:  David D Waddell
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

8.  Intra-articular glenohumeral injections of HYADD®4-G for the treatment of painful shoulder osteoarthritis: a prospective multicenter, open-label trial.

Authors:  Giuseppe Porcellini; Giovanni Merolla; Nicola Giordan; Paolo Paladini; Andrea Burini; Eugenio Cesari; Alessandro Castagna
Journal:  Joints       Date:  2016-01-28

9.  Viscosupplementation for grade II osteoarthritis of the ankle: a prospective study at 18 months' follow-up.

Authors:  Deianira Luciani; Matteo Cadossi; Federico Tesei; Eugenio Chiarello; Sandro Giannini
Journal:  Chir Organi Mov       Date:  2008-12-06

Review 10.  Viscosupplementation for the treatment of osteoarthritis of the knee.

Authors:  N Bellamy; J Campbell; V Robinson; T Gee; R Bourne; G Wells
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.